UKAD v William Ohuaregbe (First Instance and Appeal)

To optimise for archiving, the original image and related documents associated with this article have been removed.

Both First Instance and Appeal Decisions in the cases of UK Anti-Doping v William Ohuaregbe (Basketball England) and UK Anti-Doping v William Ohuaregbe (Cross-Appeal) have been published by the National Anti-Doping Panel (NADP).

On 10 March 2019, William Ohuaregbe, a licensed competitor of Basketball England, was subject to In-Competition testing following the British Basketball League Trophy Final between London City Royals and London Lions held in Glasgow.

Analysis of Mr Ohuaregbe’s urine samples returned an Adverse Analytical Finding (“AAF”) for ostarine. Mr Ohuaregbe was subsequently charged with an Anti-Doping Rule Violation (ADRV) for the Presence of a Prohibited Substance under UK Anti-Doping Rule (ADR) Article 2.1 and the matter was referred to the NADP for determination.

The NADP Tribunal consisting of Mr Charles Hollander QC (Chairperson), Professor Gordon McInnes and Ms Carole Billington-Wood concluded that Mr Ohuaregbe established that the ADRV was not ‘intentional’, but that he had failed to establish that he bore ‘No Significant Fault or Negligence’ in committing the ADRV. As a result, the Tribunal determined that the applicable period of Ineligibility to be imposed should be two years, commencing on 10 March 2019 (the date of Sample collection).

UK Anti-Doping submitted an appeal on 27 September 2019, asserting that that the Panel erred in the decision that the AAF was not ‘intentional’. Mr Ohuaregbe subsequently submitted a cross-appeal on the grounds that there was sufficient evidence to establish that he bore ‘No Significant Fault or Negligence’ on 1 October 2019.

The Arbitral Appeal Tribunal consisting of Mr Robert Englehart QC (Chair), Dr Kitrina Douglas and Professor Dorian Haskard found that the First Instance erred in their finding that Mr Ohuaregbe had discharged the burden of proof to show that his AAF was not ‘intentional’ but agreed with the First Instance Tribunal in that Mr Ohuaregbe had failed to establish that he bore ‘No Significant Fault or Negligence’. As a result, the Appeal Tribunal allowed UK Anti-Doping’s appeal and dismissed Mr Ohuaregbe’s cross-appeal, imposing a period of Ineligibility of four years.  The Appeal Tribunal agreed with the reasoning of the First Instance Tribunal that the period of Ineligibility should run from the date of Sample collection, i.e. 10 March 2019.

A copy of the full decision can be accessed via the related links tab on the right-hand side.

The National Anti-Doping Panel (NADP) is the United Kingdom’s independent tribunal responsible for adjudicating anti-doping disputes in sport. It is operated by Sport Resolutions and is entirely independent of UK Anti-Doping who is responsible for investigating, charging and prosecuting cases before the NADP.

You may also like

View All

Pinned Article

Sport Resolutions Annual Conference 2026: Early Bird Tickets Now on Sale

Early Bird tickets for the Sport Resolutions 11th Annual Conference are now available. Join leading sport and legal professionals in London on 7 May 2026 for a full day of discussion, insight, and networking

Read More

Olympic gold medallist Benita Fitzgerald Mosley named new CEO of the U.S. Center for SafeSport

Olympic 100m hurdle gold medallist Benita Fitzgerald Mosley has been appointed Chief Executive Officer of the U.S. Center for SafeSport, effective 1 February 2026

Read More

Australian Open prize pool hits record A$111.5m after Tennis Australia revenue surge

Following a significant rise in its revenue, Tennis Australia has increased the Australian Open prize pool money to a record high amount, however, it is reported that players will still “likely be disappointed”

Read More